Oct 26, 2021
We talk to Dr Emma Roffe, Oncology Country Head, Takeda UK, and Eric Low, Founder, Myeloma UK, about the challenge of combination treatments. The two discuss a pair of whitepapers recently produced by Takeda, which uncover why challenges exist, why for so long it has been classified as ‘too hard to solve’, as well...
Oct 19, 2021
We talk to Massimiliano Siciliano, Digital Solution Director Europe, Novartis, about the potential of digital solutions for the pharmaceutical industry’s stakeholders and commercial teams, the technology he is most excited about within pharma’s digital revolution, and his three key principles for building...
Oct 12, 2021
We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry’s drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores...
Oct 5, 2021
This week, we look back at the highlights in pharma throughout September, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing standouts, and the latest in research and development news.